Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?
Author:
Natale Francesco1, Franzese Rosa12, Marotta Luigi12, Mollo Noemi12, Solimene Achille12, Luisi Ettore12, Gentile Carmine12, Loffredo Francesco S.12, Golino Paolo12ORCID, Cimmino Giovanni23ORCID
Affiliation:
1. Vanvitelli Cardiology Unit, Monaldi Hospital, 80131 Naples, Italy 2. Department of Translational Medical Sciences, Section of Cardiology, University of Campania Luigi Vanvitelli, 80131 Naples, Italy 3. Cardiology Unit, AOU Luigi Vanvitelli, 80138 Naples, Italy
Abstract
The role of cholesterol, mainly low-density lipoproteins (LDL-C), as a causal risk factor for atherosclerotic cardiovascular disease (ASCVD) is now established and accepted by the international scientific community. Based on this evidence, the European and American guidelines recommend early risk stratification and “rapid” achievement of the suggested target according to the risk estimation to reduce the number of major cardiovascular events. Prolonged exposure over the years to high levels of LDL-C is one of the determining factors in the development and progression of atherosclerotic plaque, on which the action of conventional risk factors (cigarette smoking, excess weight, sedentary lifestyle, arterial hypertension, diabetes mellitus) as well as non-conventional risk factors (gut microbiota, hyperuricemia, inflammation), alone or in combination, favors the destabilization of the atherosclerotic lesion with rupture/fissuration/ulceration and consequent formation of intravascular thrombosis, which leads to the acute clinical manifestations of acute coronary syndromes. In the current clinical practice, there is a growing number of cases that, although extremely common, are emblematic of the concept of long-term exposure to the risk factor (LDL hypercholesterolemia), which, not adequately controlled and in combination with other risk factors, has favored the onset of major cardiovascular events. The triple concept of “go lower, start earlier and keep longer!” should be applied in current clinical practice at any level of prevention. In the present manuscript, we will review the current evidence and documents supporting the causal role of LDL-C in determining ASCVD and whether it is time to remove it from any score.
Reference124 articles.
1. Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel;Boren;Eur. Heart J.,2020 2. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths;Lewington;Lancet,2007 3. Emerging Risk Factors Collaboration, Di Angelantonio, E., Gao, P., Pennells, L., Kaptoge, S., Caslake, M., Thompson, A., Butterworth, A.S., Sarwar, N., and Wormser, D. (2012). Lipid-Related Markers and Cardiovascular Disease Prediction. JAMA, 307, 2499–2506. 4. Low-Density Lipoprotein Cholesterol Is Predominantly Associated with Atherosclerotic Cardiovascular Disease Events in Patients with Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry;Mortensen;Circulation,2023 5. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017
|
|